Viscosupplementation Market worth USD 55,010.42 million by 2033

The Market Statsville Group (MSG) publishes the new report on the "Viscosupplementation Market by Product Type (Single Injection, Three Injection, and Five Injection), by End-Users (Hospitals and Orthopaedic Clinics/ASCs), by Application (High Profile Cranes, and Low Profile Cranes) and by Region – Global Share and Forecast to 2033

According to the Market Statsville Group (MSG), the global Viscosupplementation market size is expected to grow at a CAGR of 4.2% from 2023 to 2033.

The increasing geriatric population, rising prevalence & incidence of osteoarthritis, and growing lifestyle-induced disorders are some factors expected to drive the market's growth during the forecast period across the globe. For instance, the prevalence of OA is increasing due to population aging and an increase in related factors such as obesity. According to the United Nations, by 2050, people over 60 will account for more than 20% of the world’s population. Of that 20%, a conservative estimate of 15% will have symptomatic OA, and one-third will be severely disabled. This states that by 2050, 130 million people will suffer from OA worldwide, of whom the disease will severely disable 40 million. Hence, the growing geriatric population and prevalence of OA will increase the demand for the viscosupplements to manage the diseases, promoting the market's growth during the forecasting period.

In addition to knee osteoarthritis, viscosupplementation market companies are exploring opportunities for growth by expanding their treatment options for hip and hand osteoarthritis. Manufacturers are focusing on developing innovative synovial fluids that thicken under pressure and act as shock absorbers, expanding their production capabilities to meet the growing demand for synthetic products. This shift towards non-animal sourced products is driving exponential growth in the market landscape.

To enhance patient outcomes, companies in the viscosupplementation market are promoting the use of combination treatments, such as gel injections with knee bracing. Recent studies have shown that gel injections may be more effective when combined with knee bracing, particularly in patients with moderate-grade knee arthritis. In response, companies are increasing their R&D efforts to develop new combination therapies using stem cells, particularly for patients with severe knee arthritis. This increased focus on combination therapies is expected to drive the growth of the viscosupplementation market in the coming years.

Global Viscosupplementation Market Segmentation

The overall viscosupplementation market has been segmented into application and region.

• By ProductType (Single Injection, Three Injection, and Five Injection)
• By End-Users (Hospitals and Orthopaedic Clinics/ASCs)
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Orthopedic Clinics/ASCs segment is projected to witness the highest CAGR during the forecast period

Orthopedic Clinics/ASCs segment is expected to grow at the highest CAGR of 9.7% during the forecast period. This growth can be attributed to various factors, such as the increasing prevalence of osteoarthritis and the growing demand for minimally invasive surgical procedures. Orthopedic clinics and ASCs are specialized healthcare facilities that focus on the diagnosis, treatment, and management of musculoskeletal disorders, including osteoarthritis. These facilities offer several advantages over traditional hospital settings, including lower costs, shorter hospital stays, and faster recovery times.

Don't miss out on business opportunities in Viscosupplementation Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the significant growth during the forecast period

North America is expected to witness significant growth in the Viscosupplementation market. The United States and Canada have some of the highest rates of osteoarthritis globally, particularly in the aging population. This has led to a growing demand for effective treatment options, such as viscosupplementation, to manage the symptoms of the disease. Furthermore, the increasing adoption of minimally invasive surgical procedures in North America is driving the growth of the viscosupplementation market. Patients are increasingly seeking less invasive treatments with fewer side effects, leading to a rise in the popularity of viscosupplementation. The availability of advanced healthcare facilities, including specialized orthopedic clinics and ASCs, also contributes to the growth of the viscosupplementation market in North America. These facilities provide patients access to the latest treatments and technologies, including viscosupplementation.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the viscosupplementation market. It also consists of the profiles of leading companies such as Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Biomet, Smith & Nephew Plc, LG Chem, Lifecore, Ferring B.V., and Fidia Farmaceutici S.p.A. The key players' growing research and development activities for innovative solutions are expected to drive market growth.

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

800 Third Avenue Suite A #1519

New York, US 10022

USA: +1 646-663-5829 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com